Cancer chemotherapy: early experience with combined chemotherapy for HIV-infected Kaposi's sarcoma patients at Lighthouse clinic, Lilongwe, Malawi

Background: Kaposi's sarcoma(KS) is the most common AIDS related malignancy in Malawi. National guidelines recommend chemotherapy with vincristine, along with antiretroviral treatment (ART). Effectiveness of vincristine monotherapy is limited, is considered palliative and interrupted supply contributes to poor outcomes of KS patients. Lighthouse, a major provider of HIV related services, started 38 patients on ART due to KS in quarter 1, 2010 and overall, 1195 patients ever started ART due to KS. Supplement: Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection http://www.biomedcentral.com/content/pdf/1758-2652-13-S4-info.pdf Conference: Tenth International Congress on Drug Therapy in HIV Infection 7-11 November 2010 Glasgow, UK (Published: 8 November 2010) doi:10.1186/1758-2652-13-S4-P216 Cite this article as: Mulinde et al.: Cancer chemotherapy: early experience with combined chemotherapy for HIV-infected Kaposi’s sarcoma patients at Lighthouse clinic, Lilongwe, Malawi. Journal of the International AIDS Society 2010 13(Suppl 4):P216. Full text: PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113001/